You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
JavaScript Required
JavaScript is required to use content on this page. Please enable JavaScript in your browser.
Skip to Content
Accessibility Information
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Maryland Department of Health
Genetics
Genetics
Currently selected
Sickle Cell Disease
What is Sickle Cell Disease?
What is Sickle Cell Trait?
How can SCT impact a person’s health?
What do I need to know about SCT and sports?
How is Sickle Cell Trait (SCT) Inherited?
What does the Maryland Department of Health’s Sickle Cell Disease Follow-Up Program do?
Section Menu
Office for Genetics and People with Special Health Care Needs
Currently selected
A-Z Index
Birth Defects Reporting Information System
Children's Medical Services
Critical Congenital Heart Disease
Early Hearing Detection and Intervention Program
Family Professional Partnership
Health Care Transition Program
Maternal and Child Health
Medical Home Program
Newborn Metabolic Screening
Sickle Cell Disease Follow-up Program
Special Needs Resource Locator
Recent
Left_Content
Main_Content
Update on Screening for Critical Congenital Heart Disease
(House Bill 714)
Screening for critical congenital heart disease is a very important issue that was addressed by legislation signed by Governor O’Malley last week. Most infants with critical congenital heart disease are identified before birth or because they have symptoms soon after they are born. However, about 10 to 20 babies a year in Maryland do not show any symptoms until they are sent home. While screening can save lives, the professional groups that usually establish standards of care for newborns have not yet recommended pulse oximetry screening for critical congenital heart disease as standard of care. Since there are many issues to consider in adding a new test for newborn screening, legislators, advocates and public health professionals worked together on House Bill 714 to move forward on this important issue in a thoughtful manner. The result was the legislation signed last week by the Governor which directs the State Advisory Council on Hereditary and Congenital Disorders to convene a panel of experts to review available information on pulse oximetry screening for critical congenital heart disease and provide a report to the State Legislature by December 2011. This is similar to what is going on at a national level. In a letter dated April 20, 2011, Secretary Sebelius asked for the Interagency Coordinating Committee on Newborn and Child Screening to review the information on this screening and recommend a plan of action in 90 days
http://www.hrsa.gov/heritabledisorderscommittee/correspondence/CCCHDSecResponse042011.pdf
).
The legislation signed last week does state that Maryland will begin pulse oximetry screening for newborns if this test is adopted by the Secretary of Health and Human Services. To read the entire bill, see
http://mlis.state.md.us/2011rs/bills/hb/hb0714t.pdf
Center_Content